Benjamin Thuma
12Patents
6h-index
16Co-inventors
59Inventor score
Filing activity: Nov 13, 2007 → Mar 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9340553B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 11 | Active |
| US9617293B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 11 | Active |
| US10039778B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 8 | Active |
| US10376531B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 7 | Active |
| US10813942B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 7 | Active |
| US9809579B2 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US10174007B2 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10787438B2 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10988463B2 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10851367B2 | Tissue-specific genome engineering using CRISPR-Cas9 | Chemistry; Metallurgy | 1 | Active |
| US11634410B2 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7615651B2 | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.